FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2951782016> ?p ?o ?g. }

• W2951782016 endingPage "1007" @default.
• W2951782016 startingPage "997" @default.
• W2951782016 abstract "Gefitinib, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has showed remarkable activity in non-small cell lung cancer patients with tumors carrying sensitive EGFR mutation. However, Iressa® tablets present problems, including insolubility, large absorption disparity, low oral bioavailability, gastrointestinal side effects and drug resistance, which limit their application. In present study, we developed gefitinib-loaded human serum albumin nanoparticles (GFNPs) by Nab™ technology for intravenous administration. By utilizing oleic acid as a co-emulsifier, which could increase the binding of gefitinib to human serum albumin, GFNPs were successfully fabricated with an amorphous state in GFNPs and its release from the nanoparticles conformed to the Ritger-Peppas process. The albumin nanoparticles could rapidly disassociate in the bloodstream and were effectively uptaken by the NCI–H358 cells via the mechanisms of secreted protein acidic and rich in cysteine (SPARC)-mediated transport, resulting in higher growth inhibition and apoptosis induction compared to free gefitinib. In tumor-bearing mice, the albumin nanoparticles demonstrated an increased, lasting tumor distribution. Compared with the commercial Iressa, GFNPs at only 10% of Iressa dose showed superior antitumor efficacy, with little effect on body weight of mice, suggesting that GFNPs might serve as a clinical candidate for a safe and effective anti-non-small cell lung cancer treatment." @default.
• W2951782016 created "2019-06-27" @default.
• W2951782016 creator A5000363531 @default.
• W2951782016 creator A5004136136 @default.
• W2951782016 creator A5011738757 @default.
• W2951782016 creator A5021291667 @default.
• W2951782016 creator A5023222921 @default.
• W2951782016 creator A5051242165 @default.
• W2951782016 creator A5054769778 @default.
• W2951782016 creator A5061085532 @default.
• W2951782016 creator A5073580794 @default.
• W2951782016 creator A5082468101 @default.
• W2951782016 creator A5088657899 @default.
• W2951782016 date "2019-08-01" @default.
• W2951782016 modified "2023-10-14" @default.
• W2951782016 title "Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer" @default.
• W2951782016 cites W117344349 @default.
• W2951782016 cites W1846575105 @default.
• W2951782016 cites W1965827111 @default.
• W2951782016 cites W1969357813 @default.
• W2951782016 cites W1973107158 @default.
• W2951782016 cites W1975586699 @default.
• W2951782016 cites W1980670479 @default.
• W2951782016 cites W1982022971 @default.
• W2951782016 cites W1982628018 @default.
• W2951782016 cites W1989906769 @default.
• W2951782016 cites W2002815709 @default.
• W2951782016 cites W2017333482 @default.
• W2951782016 cites W2019366306 @default.
• W2951782016 cites W2024917180 @default.
• W2951782016 cites W2028534743 @default.
• W2951782016 cites W2030173263 @default.
• W2951782016 cites W2037555314 @default.
• W2951782016 cites W2038717222 @default.
• W2951782016 cites W2040689370 @default.
• W2951782016 cites W2042278676 @default.
• W2951782016 cites W2059159382 @default.
• W2951782016 cites W2060567277 @default.
• W2951782016 cites W2061107749 @default.
• W2951782016 cites W2066742760 @default.
• W2951782016 cites W2068254287 @default.
• W2951782016 cites W2075437391 @default.
• W2951782016 cites W2084907141 @default.
• W2951782016 cites W2086924703 @default.
• W2951782016 cites W2090210876 @default.
• W2951782016 cites W2098298686 @default.
• W2951782016 cites W2116717202 @default.
• W2951782016 cites W2126652977 @default.
• W2951782016 cites W2142504874 @default.
• W2951782016 cites W2145532552 @default.
• W2951782016 cites W2156316554 @default.
• W2951782016 cites W2257175382 @default.
• W2951782016 cites W2272984102 @default.
• W2951782016 cites W2332019648 @default.
• W2951782016 cites W2492412658 @default.
• W2951782016 cites W2521161105 @default.
• W2951782016 cites W2555156914 @default.
• W2951782016 cites W2810476274 @default.
• W2951782016 doi "https://doi.org/10.1016/j.jddst.2019.06.011" @default.
• W2951782016 hasPublicationYear "2019" @default.
• W2951782016 type Work @default.
• W2951782016 sameAs 2951782016 @default.
• W2951782016 citedByCount "14" @default.
• W2951782016 countsByYear W29517820162019 @default.
• W2951782016 countsByYear W29517820162020 @default.
• W2951782016 countsByYear W29517820162021 @default.
• W2951782016 countsByYear W29517820162022 @default.
• W2951782016 countsByYear W29517820162023 @default.
• W2951782016 crossrefType "journal-article" @default.
• W2951782016 hasAuthorship W2951782016A5000363531 @default.
• W2951782016 hasAuthorship W2951782016A5004136136 @default.
• W2951782016 hasAuthorship W2951782016A5011738757 @default.
• W2951782016 hasAuthorship W2951782016A5021291667 @default.
• W2951782016 hasAuthorship W2951782016A5023222921 @default.
• W2951782016 hasAuthorship W2951782016A5051242165 @default.
• W2951782016 hasAuthorship W2951782016A5054769778 @default.
• W2951782016 hasAuthorship W2951782016A5061085532 @default.
• W2951782016 hasAuthorship W2951782016A5073580794 @default.
• W2951782016 hasAuthorship W2951782016A5082468101 @default.
• W2951782016 hasAuthorship W2951782016A5088657899 @default.
• W2951782016 hasConcept C121608353 @default.
• W2951782016 hasConcept C126322002 @default.
• W2951782016 hasConcept C155672457 @default.
• W2951782016 hasConcept C165616093 @default.
• W2951782016 hasConcept C171250308 @default.
• W2951782016 hasConcept C181389837 @default.
• W2951782016 hasConcept C185592680 @default.
• W2951782016 hasConcept C190283241 @default.
• W2951782016 hasConcept C192562407 @default.
• W2951782016 hasConcept C204399865 @default.
• W2951782016 hasConcept C2776125364 @default.
• W2951782016 hasConcept C2779438470 @default.
• W2951782016 hasConcept C2780580887 @default.
• W2951782016 hasConcept C502942594 @default.
• W2951782016 hasConcept C55493867 @default.
• W2951782016 hasConcept C71924100 @default.
• W2951782016 hasConcept C98274493 @default.
• W2951782016 hasConceptScore W2951782016C121608353 @default.

• next